To view this content, you need to sign in.
You should only be asked to sign in once. Not the case? Click here
Register now to access this content and more for free.
Cell therapy company Vor Biopharma raises $176.9m for IPO
Vor Biopharma, a cell therapy company, has raised about $176.9 million for its IPO after pricing its over 9.8 million shares at $18 per share.
